Cargando…

Juvenile overlap myositis: retrospective study about 20 cases

Detalles Bibliográficos
Autores principales:	Piccolo, Vanessa Remy, Lambot, Karen, Breton, Sylvain, Ferneiny, Marie, Gitiaux, Cyril, Quartier, Pierre, Bodemer, Christine, Bader-Meunier, Brigitte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184359/ http://dx.doi.org/10.1186/1546-0096-12-S1-P92

Ejemplares similares

Clinical characteristics, management and outcomes in patients with juvenile dermatomyositis requiring admission in pediatric intensive care unit
por: Besancon, Alix, et al.
Publicado: (2014)

Mosaic tetrasomy 9p: a mendelian interferonopathy associated with pediatric-onset overlap myositis
por: Frémond, M-L, et al.
Publicado: (2015)

Clinical features of children with enthesitis-related juvenile idiopathic arthritis / juvenile spondyloarthritis followed in a French tertiary care pediatric rheumatology centre
por: Goirand, Maxime, et al.
Publicado: (2018)

PReS-FINAL-2111: Cytomegalovirus, Epstein Barr virus and Varicella-Zoster virus infections in children with juvenile idiopathic arthritis treated with biologics
por: Remy Piccolo, V, et al.
Publicado: (2013)

Dry synovitis, a rare entity distinct from juvenile idiopathic arthritis
por: De Somer, Lien, et al.
Publicado: (2023)

Juvenile idiopathic arthritis with dry synovitis: clinical and imaging aspects in a cohort of 6 patients
por: De Somer, L, et al.
Publicado: (2011)

Update in juvenile myositis
por: Nistala, Kiran, et al.
Publicado: (2013)

Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis
por: Morelle, Guillaume, et al.
Publicado: (2021)

PW03-033 - SLC29A3 mutation: a new autoinflammatory condition
por: Melki, I, et al.
Publicado: (2013)

Probable DRESS syndrome induced by IL-1 inhibitors
por: Polivka, L., et al.
Publicado: (2017)

Respiratory involvement in juvenile dermatomyositis
por: Fabi, M, et al.
Publicado: (2008)

Ipilimumab/nivolumab: Myocarditis-myositis overlap syndrome and ocular myositis: case report
Publicado: (2020)

Targeting the chemokine receptor CXCR4 with histamine analog to reduce inflammation in juvenile arthritis
por: Bekaddour, Nassima, et al.
Publicado: (2023)

Systemic-onset juvenile rheumatoid arthritis and ANCA-associated glomerulonephritis
por: Belot, A, et al.
Publicado: (2008)

Juvenile dermatomyositis (JDM) sine myositis
por: Schuetz, C, et al.
Publicado: (2011)

PReS-FINAL-2133: Drug survival and switching of biological agents in systemic juvenile idiopathic arthritis
por: Woerner, A, et al.
Publicado: (2013)

Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes
por: Urien, Saik, et al.
Publicado: (2013)

Systemic onset Juvenile Idiopathic Arthritis (SoJIA): a monocentric study of 114 patients
por: Melki, I, et al.
Publicado: (2011)

Simultaneous Combined Myositis, Inflammatory Polyneuropathy, and Overlap Myasthenic Syndrome
por: Mathis, Stéphane, et al.
Publicado: (2016)

Systemic lupus erythematosus-myositis overlap syndrome with lupus nephritis
por: Dey, Biswajit, et al.
Publicado: (2020)

Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent
por: Woerner, A, et al.
Publicado: (2015)

Novel autoantibodies and clinical phenotypes in adult and juvenile myositis
por: Betteridge, Zoe E, et al.
Publicado: (2011)

The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies
por: Rider, Lisa G., et al.
Publicado: (2013)

The French version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Quartier, Pierre, et al.
Publicado: (2018)

Nailfold capillaroscopy changes with disease activity in patients with inflammatory myositis including overlap myositis, pure dermatomyositis, and pure polymyositis
por: Shenavandeh, Saeedeh, et al.
Publicado: (2022)

14.2 Causes of early death in juvenile onset systemic lupus erythematosus (JSLE)
por: Bader-Meunier, B, et al.
Publicado: (2008)

Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care
por: Papadopoulou, Charalampia, et al.
Publicado: (2023)

Clinical, Serological, and Genetic Characteristics of a Hungarian Myositis-Scleroderma Overlap Cohort
por: Szabó, Katalin, et al.
Publicado: (2022)

Myocarditis-myositis-myasthenia gravis overlap syndrome depending on immune checkpoint inhibitor
por: Ünlütürk, Zeynep, et al.
Publicado: (2023)

Biologics in refractory myositis: experience in juvenile vs. adult myositis; part II: emerging biologic and other therapies on the horizon
por: Patwardhan, Anjali, et al.
Publicado: (2019)

Safety of rituximab in children with auto-immune diseases
por: Bader-Meunier, B, et al.
Publicado: (2008)

OA20 Pneumatosis intestinalis with spontaneous pneumoperitoneum in a patient with systemic sclerosis-myositis overlap syndrome: a case report and review of the literature
por: Lim, Kian Wah, et al.
Publicado: (2022)

Assessment of Type I Interferon Signaling in Pediatric Inflammatory Disease
por: Rice, Gillian I., et al.
Publicado: (2016)

Isolated anti-Ku antibody in scleroderma-myositis overlap syndrome: the histo-pathological patern
por: Azanmene, Bernard, et al.
Publicado: (2012)

PReS13-SPK-1030: Juvenile dermatomyositis
por: Quartier, P
Publicado: (2013)

Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection
por: Rodero, Mathieu Paul, et al.
Publicado: (2021)

Criteria Associated with Treatment Decisions in Juvenile Idiopathic Arthritis with a Focus on Ultrasonography: Results from the JIRECHO Cohort
por: Baydoun, Sara, et al.
Publicado: (2022)

Sintilimab-Induced Myocarditis Overlapping Myositis in a Patient With Metastatic Thymoma: A Case Report
por: Yang, Zi-xuan, et al.
Publicado: (2021)

Safety, effectiveness, and pharmacokinetics of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to 4 years
por: Kingsbury, Daniel J., et al.
Publicado: (2014)

Correction to: Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection
por: Rodero, Mathieu Paul, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8h9c0hnnukld68lndul75545cq